Assessing venous thromboembolism risk in lung cancer: a comprehensive evaluation of the khorana score, clinical characteristics, and incidence of thrombosis

IntroductionVenous thromboembolism (VTE) occurrence in patients with lung cancer is associated with significant morbidity and mortality. The Khorana Score (KRS) is a validated risk stratification tool developed to estimate risk of VTE in patients with cancer that incorporates clinical and laboratory...

Descrición completa

Detalles Bibliográficos

Principais autores:	Sean C. Dougherty, Rishika Singh, Caleb McKinney, Aditya Singh, Jack Masur, Alia C. Lynch, Ryan D. Gentzler, Wendy Novicoff, Nathan Roberts, Richard D. Hall
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2026-01-01
Series:	Frontiers in Oncology
Assuntos:	khorana risk score non-small cell lung cancer oncogenic driver mutation small cell lung cancer venous thromboembolism
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1651192/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!